AbbVie Continues To Pursue Irish Drugmaker Shire With Higher Offer - Presented by: The Aol. On Network

Three rejections and still trying. That sums up U.S. drugmaker AbbVie's pursuit of the London listed bio-pharmaceutical giant, Shire. After AbbVie's latest unsuccessful $46 billion bid to gain control of Shire, AbbVie upped it's offer to $51 billion. Shire CEO Flemming Ornskov previously said that he was not against a buyout, but needed the right price. So is $51 billion the right price?



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.94 0.09 ▼ 0.53%
PBR $ 8.20 0.63 ▼ 7.13%
SIRI $ 3.68 0.05 ▼ 1.34%
MU $ 18.32 0.75 ▼ 3.93%
FTR $ 4.92 0.07 ▲ 1.44%
INTC $ 30.04 0.52 ▼ 1.69%
SFUN $ 7.13 1.19 ▼ 14.30%
VALE $ 5.61 0.24 ▼ 4.10%

As of 7/6/2015, 04:15 PM